期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Targeted Oncology LetPub Score 7.3
50 ratings
Rate
Reputation 8.8 Influence 6.1 Speed 7.0 | ||||||||||||||||||||||||
期刊簡稱 | TARGET ONCOL | ||||||||||||||||||||||||
ISSN | 1776-2596 | ||||||||||||||||||||||||
E-ISSN | 1776-260X | ||||||||||||||||||||||||
h-index | 35 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 2.30%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | https://www.springer.com/11523 | ||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/targ | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Springer International Publishing | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | FRANCE | ||||||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||||||
創刊年 | 2006 | ||||||||||||||||||||||||
每年文章數 | 70每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 51.26% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1776-2596%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: >12 Week(s), or Invited contributions | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[Targeted Oncology] 的評論 | 撰寫評論 |
作者: 混元新曦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-18 13:04:05 評論於 The article about tumors is very easy, it will be hired in a minute(0) 讚! | 混元新曦 |
作者: 耀择来了 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-08 16:39:51 評論於 The requirements of this magazine are difficult to understand, as they request rejected peer review feedback and explanations. It's just too much, providing rejected peer review feedback will only result in being rejected again(0) 讚! | 耀择来了 |
作者: 拈花怀青 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-22 10:54:06 評論於 May I ask how you are doing now?(0) 讚! | 拈花怀青 |
作者: 龙鳞倩云 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-08 20:13:15 評論於 Research focus: Cancer; Experience sharing on review: It has been 4 days since submission, and it has always been "new submission". I don't know what the situation is. Should I follow up?(0) 讚! | 龙鳞倩云 |
作者: 龙鳞倩云 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-07 20:32:27 評論於 Heavy research direction: Summary of shared experiences: It has been 4 days since submission, and it has always been 'new submission'. Does anyone have the same situation? Should I send a reminder?(0) 讚! | 龙鳞倩云 |
作者: 岳家园园 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-31 21:04:00 評論於 Is it free? Is this a service?(0) 讚! | 岳家园园 |
作者: 打狗瑞芝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-11 15:01:14 評論於 Can you tell me how long the status of "new submission" will last?(0) 讚! | 打狗瑞芝 |
作者: 一条小醉霜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-05 12:09:34 評論於 What's going on now?(0) 讚! | 一条小醉霜 |
作者: 五虎煜喆 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-30 17:20:22 評論於 It's been ten days, still no new submission(0) 讚! | 五虎煜喆 |
作者: 五虎煜喆 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-27 08:56:24 評論於 It has been 7 days and I am still a new submission(0) 讚! | 五虎煜喆 |
作者: 书生永寿 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-05 17:39:26 評論於 I also submitted my work two days ago and it is still New Submission(0) 讚! | 书生永寿 |
作者: Baron Jonah 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-25 22:02:16 評論於 Do you want the raw data?(0) 讚! | Baron Jonah |
作者: 奇正小可爱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-12 17:53:59 評論於 Bro, how are you doing?(0) 讚! | 奇正小可爱 |
作者: 奇正小可爱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-09 08:10:18 評論於 Brother, have you voted?(0) 讚! | 奇正小可爱 |
作者: 五轮艺天 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-10 12:41:36 評論於 Is the review process fast?(0) 讚! | 五轮艺天 |
作者: 五轮艺天 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-01-14 17:13:35 評論於 How many days does it take for the submission to reach the editor's hands?(0) 讚! | 五轮艺天 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 14:27:56 評論於 Abstracts include some common key parts, each part consisting of about one to two sentences, such as background, aim or purpose of research, method used, findings/results, and conclusion(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 09:26:35 評論於 The research objective describes the research background and explains why this study is being conducted. It is a necessary element for writing an abstract(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 深渊兴业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 20:01:40 評論於 Do we have to include the research objectives in the abstract?(0) 讚! | 深渊兴业 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 16:08:08 評論於 How to write an abstract? Is there a template?(0) 讚! | 北国博达 |
作者: 中原红螺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-04-29 22:16:04 評論於 When will your submission be delivered to the editor's hands?(0) 讚! | 中原红螺 |
作者: Bruce Nicholas 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-03-06 14:37:30 評論於 Is anyone reviewing submissions? Why is my submission still showing as "New Submission" after several days?(0) 讚! | Bruce Nicholas |
作者: 白云庚辰 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-02-20 21:07:10 評論於 In the "corresponding author" section of the TARGETED ONCOLOGY Conflict of Interest disclosure form, should I indicate whether or not there is a conflict of interest, or should I provide the name of the corresponding author?(0) 讚! | 白云庚辰 |
作者: 中原子超 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-11-21 19:18:37 評論於 Hello, are the magazines recommended by them all included in SCI?(0) 讚! | 中原子超 |
作者: 中原子超 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-11-21 11:10:09 評論於 Are the magazines recommended by them the same as those included in SCI?(0) 讚! | 中原子超 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us